openPR Logo
Press release

Global Cancer Biomarkers Market is Determined to Cross US$ 157.00 Billion By 2022

10-16-2017 11:17 AM CET | Health & Medicine

Press release from: (MRE) Report

Cancer Biomarkers Market

Cancer Biomarkers Market

In this report, the global cancer biomarkers market is segmented by cancer type, application, profiling technology, biomolecules, and region. The market on the basis of cancer type is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, stomach cancer, and others. On the basis of application, the market is segmented into diagnostics, drug discovery & development, prognostics, risk assessment, and others. The market by profiling technology is segmented into Omic technology, imaging technology, immunoassays, and cytogenetics-based tests. On the basis of biomolecules, the market is segmented into genetic biomarkers, protein biomarkers, and glycoprotein biomarkers.

The global cancer biomarkers market is expected to exceed US$ 157.37 billion by 2022, registering a compound annual growth rate (CAGR) of 13.3% during the forecast period.

A glimpse of the report structure is provided in the report description available on the website.
https://www.marketresearchengine.com/cancer-biomarkers-market

F.Hoffmann-La Roche Ltd., Abbott Laboratories, GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Inc., Qiagen N.V., and Genomic Health, Inc. are the most active players in the cancer biomarkers market.

The increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, and low cost of clinical trials in developing countries are expected to drive the market. In addition, the high prevalence of cancer and new initiatives for biomarker research are expected to fuel the growth of the market. However, the high capital investments and low cost-benefit ratio, poorly suited government regulations and reimbursement policies, and technical issues related to sample collection and storage are restricting the growth of the market.

The Global Cancer Biomarkers Market has been segmented as below:

By Cancer Type Analysis:
• Lung Cancer
• Breast Cancer
• Colorectal Cancer
• Prostate Cancer
• Stomach Cancer
• Other Cancers

By Application Analysis:
• Diagnostics
• Drug Discovery and Development
• Prognostics
• Risk Assessment
• Others

By Profiling Technology Analysis:
• Omic Technologies
• Imaging Technologies
• Immunoassays
• Cytogenetics Based Tests

By Biomolecules Analysis:
• Genetic Biomarkers
• Protein Biomarkers
• Glycoprotein Biomarkers

By Regional Analysis:
• North America
• Europe
• Asia-Pacific
• Rest of the World

This report covers the cancer biomarkers market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

Request Free Sample Report: https://www.marketresearchengine.com/cancer-biomarkers-market

The deep-dive study on the cancer biomarkers market will help customers with the identification of new market opportunities and targeted promotional plans.

Table of Contents

1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Biomarkers Market, By Product
7 Biomarkers Market, By Type
8 Biomarkers Market, By Application
9 Biomarkers Market, By Disease Indication
10 Biomarkers Market, By Region
11 Competitive Landscape
12 Company Profiles
12.1 Qiagen N.V.
12.2 Perkinelmer, Inc.
12.3 Merck Millipore
12.4 Bio-Rad Laboratories, Inc.
12.5 Enzo Biochem, Inc.
12.6 EKF Diagnostics Holdings, Inc.
12.7 Meso Scale Diagnostics, LLC.
12.8 Biosims Technologies Sas
12.9 Cisbio Bioassays
12.10 Signosis, Inc.

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Biomarkers Market is Determined to Cross US$ 157.00 Billion By 2022 here

News-ID: 774471 • Views:

More Releases from (MRE) Report

Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018: Weight Management Market 2018 The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018: Home Healthcare Market 2018 The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018: Healthcare 3D Printing Market 2018 The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018: Tumor Ablation Market 2018 The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed

All 5 Releases


More Releases for Biomarkers

Biomarkers Market Soars: Safety Biomarkers Lead with 15.9% Projected Growth from …
The global biomarkers market size was valued at US$ 59.1 Billion in 2021 and is expected to expand at a compound annual growth rate CAGR of 15.3% from 2022 to 2032. Safety Biomarkers are expected to be the highest revenue generating biomarker type, with a projected growth of 15.9% from 2022-2032. Biomarkers, or biological indicators, have revolutionized the fields of medicine and healthcare by enabling early disease detection, personalized treatment, and
Neurological Biomarkers Market - Decoding Brain Health: Biomarkers Revolutionizi …
Newark, New Castle, USA: The "Neurological Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Neurological Biomarkers Market: https://www.growthplusreports.com/report/neurological-biomarkers-market/8040 This latest report researches the industry structure, sales, revenue,
Cardiac Biomarkers Market - Unveiling Heart Health: Biomarkers Revolutionizing C …
Newark, New Castle, USA: The "Cardiac Biomarkers Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cardiac Biomarkers Market: https://www.growthplusreports.com/report/cardiac-biomarkers-market/8024 This latest report researches the industry structure, sales, revenue,
Global Companion Diagnostic Cancer Biomarkers Market by types (Protein Biomarker …
Global Companion Diagnostic Cancer Biomarkers Market Research Report” Purchase This Report by calling ResearchnReports.com at +1-888-631-6977. The report, titled Companion Diagnostic Cancer Biomarkers presents an in-depth study of the Companion Diagnostic Cancer Biomarkers market. Providing a brief history about the market, the report analyses the entire value chain of the market and points out the key drivers and restraints affecting the growth of the market during the forecast period. The report
Global Biomarkers Market Propelled by Growing Usage of Biomarkers in Medical Are …
A biomarker refers to a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures, and biological procedures. Also known as a molecular marker or signature molecule, biomarkers are found in blood, other body fluids, and tissue. Extensively used to see the body’s response to a particular treatment for a disease or condition, biomarkers assist medical professionals to take effective clinical decisions and help
Biomarkers Summit
SMi present their 4th annual conference on Biomarkers Summit Monday 31st January & Tuesday 1st February 2011 Crowne Plaza The-City, London, UK Don’t Miss Out - Visit to register your place today http://www.smi-online.co.uk/preclinical-biomarkers.asp Sponsored by Caprotec Cell Signalling Technology GVK Bio Selventa Millipore Quest Diagnostics RBM SMi’s highly anticipated 4th annual Biomarkers Summit is fast approaching, and time is running out